Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis

Last updated: May 14, 2020
Sponsor: Actavis Inc.
Overall Status: Completed

Phase

3

Condition

Atopic Dermatitis

Allergy

Hives (Urticaria)

Treatment

N/A

Clinical Study ID

NCT02791308
SYM 2014-03
  • Ages 12-90
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to compare the safety and efficacy profiles of Watson Laboratories, Inc.'s Pimecrolimus Cream, 1% to those of Valeant Pharmaceuticals North America LLC's Elidel® (pimecrolimus) Cream, 1%, and to demonstrate the superior efficacy of the two active creams over that of the placebo (Vehicle of test product), in the treatment of mild to moderate atopic dermatitis.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Willing and able to provide written informed consent/assent for the study.

  • Non-immunocompromised male or female aged 12 years or older.

  • A clinical diagnosis of mild to moderate atopic dermatitis that has failed to respondadequately to other topical prescription treatments for atopic dermatitis, or subjectsfor whom the use of those other treatments is deemed inadvisable.

  • A diagnosis of atopic dermatitis for at least 3 months.

  • A baseline Investigator's Global Assessment (IGA) of disease severity of mild ormoderate (score of 2 or 3).

  • An affected area of atopic dermatitis involvement of at least 5% of the body surfacearea (BSA) at Visit 2/Day 1 (Baseline), as defined by the criteria of Hanifin andRajka (1980).

  • Treatment with a bland emollient for at least 7 days prior to Visit 2/Day 1 (Baseline).

  • Agree to adhere to protocol-specified requirements and concomitant therapyrestrictions.

  • Willing to avoid constant sun exposure and the use of tanning booths or other UV lightsources during participation in the study.

  • In general good health, non-immunocompromised, and free from any clinicallysignificant disease, other than atopic dermatitis, that might interfere with the studyevaluations.

  • Willing and able to understand and comply with the requirements of the study, applythe study medication as instructed, return for the required study visits, comply withtherapy prohibitions, and complete the study.

  • Female subjects of childbearing potential (excluding women who are surgicallysterilized [hysterectomy, bilateral tubal ligation, or bilateral ovariectomy] or havebeen postmenopausal for at least 1 year) must have a negative urine pregnancy test andmust be willing to use a medically accepted method of contraception during the study.The following are considered acceptable methods of birth control for the purpose ofthis study: oral contraceptives, contraceptive patches, contraceptive implant, vaginalcontraceptive, double barrier methods (e.g., condom and spermicide), contraceptiveinjection (Depo-Provera®), intrauterine device (IUD), hormonal IUD (Mirena®), Essure®permanent birth control, and abstinence with a documented second acceptable method ofbirth control if the subject becomes sexually active. Subjects entering the study whoare on hormonal contraceptives must have been on the method for at least 90 days priorto the study and continue the method for the duration of the study. Subjects who hadused hormonal contraception and stopped must have stopped no less than 90 days priorto Visit 1.

Exclusion

Exclusion Criteria:

  • Females who were pregnant, breastfeeding, intending to become pregnant during thestudy, or who did not agree to use an acceptable form of birth control during thestudy.

  • Active cutaneous bacterial or viral infection in any proposed treatment area at Visit 2/Baseline (e.g., clinically infected atopic dermatitis).

  • Sunburn, extensive scarring, or pigmented lesion(s) in any treatment area at Visit 2/Baseline that would interfere with the study evaluations.

  • History of confounding skin conditions, e.g., psoriasis, rosacea, erythroderma, orichthyosis.

  • History or presence of Netherton's Syndrome, immunological deficiencies or diseases,HIV, diabetes, malignancy, serious active or recurrent infection, clinicallysignificant severe renal insufficiency, or severe hepatic disorders.

  • Use of any treatment listed in Table 9.1 more recently than the indicated washoutperiod prior to Visit 2/Baseline.

  • Need or intent to continue to use any treatment listed in Table 9.1 during the currentstudy.

Study Design

Total Participants: 587
Study Start date:
February 01, 2015
Estimated Completion Date:
July 31, 2016

Study Description

Pimecrolimus cream, 1% is a calcineurin inhibitor immunosuppressant. Pimecrolimus inhibits T cell activation by blocking the transcription of early cytokines. Pimecrolimus cream, 1% is indicated as second-line therapy for the short-term and non-continuous chronic treatment of mild-to-moderate atopic dermatitis in non-immunocompromised adults and children 2 years of age and older who have failed to respond adequately to other topical prescription treatments, or when those treatments are not advisable. This study is being conducted to evaluate the clinical bioequivalence of sponsor's formulation of Pimecrolimus Cream, 1%, the Test product, and Elidel Cream, 1%, the Reference product. A vehicle control arm is included to demonstrate that the Test and Reference products are active and to establish that the study is sufficiently sensitive to detect differences between products.

Connect with a study center

  • Pinnacle Research Group, LLC

    Anniston, Alabama 36207
    United States

    Site Not Available

  • Clinical Research Center of Alabama

    Birmingham, Alabama 35209
    United States

    Site Not Available

  • Agave Clinical Research, LLC

    Mesa, Arizona 85202
    United States

    Site Not Available

  • Omni Dermatology/Physicians Research Group, LLC

    Phoenix, Arizona 85018
    United States

    Site Not Available

  • Northwest Arkansas Clinical Trials Center, PLLC

    Rogers, Arkansas 72758
    United States

    Site Not Available

  • MD Studies, Inc.

    Fountain Valley, California 92708
    United States

    Site Not Available

  • Alliance Research Centers

    Laguna Hills, California 92653
    United States

    Site Not Available

  • Medical Center for Clinical Research

    San Diego, California 92108
    United States

    Site Not Available

  • Skin Surgery Medical Group, Inc.

    San Diego, California 92117
    United States

    Site Not Available

  • Horizons Clinical Research Ctr., LLC

    Denver, Colorado 80220
    United States

    Site Not Available

  • Immunoe International Research Centers

    Thornton, Colorado 80233
    United States

    Site Not Available

  • Dermatology of Boca

    Boca Raton, Florida 33431
    United States

    Site Not Available

  • Olympian Clinical Research

    Clearwater, Florida 33757
    United States

    Site Not Available

  • International Dermatology Research, Inc.

    Miami, Florida 33144
    United States

    Site Not Available

  • Radiant Research, Inc.

    Pinellas Park, Florida 33781
    United States

    Site Not Available

  • International Clinical Research- US, LLC

    Sanford, Florida 32771
    United States

    Site Not Available

  • MOORE Clinical Research, Inc.

    Tampa, Florida 33609
    United States

    Site Not Available

  • Olympian Clinical Research

    Tampa, Florida 33609
    United States

    Site Not Available

  • Kansas City Dermatology PA

    Overland Park, Kansas 66215
    United States

    Site Not Available

  • Kentucky Pediatric/Adult Research

    Bardstown, Kentucky 40004
    United States

    Site Not Available

  • Dermatology Specialists Research

    Louisville, Kentucky 40202
    United States

    Site Not Available

  • Callender Center for Clinical Research, LLC

    Glenn Dale, Maryland 20769
    United States

    Site Not Available

  • David Fivenson, MD, PLC

    Ann Arbor, Michigan 48103
    United States

    Site Not Available

  • Minnesota Clinical Study Center

    Fridley, Minnesota 55432
    United States

    Site Not Available

  • MediSearch Clinical Trials

    Saint Joseph, Missouri 64506
    United States

    Site Not Available

  • MediSearch Clinical Trials

    St. Joseph, Missouri 64506
    United States

    Site Not Available

  • Quality Clinical Research Inc.

    Omaha, Nebraska 68114
    United States

    Site Not Available

  • Karl G. Heine, MD Dermatology

    Henderson, Nevada 89052
    United States

    Site Not Available

  • Academic Dermatology Associates

    Albuquerque, New Mexico 87106
    United States

    Site Not Available

  • Pinkas E. Lebovits, MD, PC

    New York, New York 10019
    United States

    Site Not Available

  • Piedmont Plastic Surgery and Dermatology

    Charlotte, North Carolina 28277
    United States

    Site Not Available

  • Dermatology Consulting Services

    High Point, North Carolina 27262
    United States

    Site Not Available

  • PMG Research of Winston-Salem, LLC

    Winston-Salem, North Carolina 27103
    United States

    Site Not Available

  • Cyn3rgy Research

    Gresham, Oregon 97030
    United States

    Site Not Available

  • Baker Allergy, Asthma and Dermatology Research Center, LLC

    Portland, Oregon 97223
    United States

    Site Not Available

  • Asthma & Allergy Research Associates

    Upland, Pennsylvania 19013
    United States

    Site Not Available

  • Clinical Partners, LLC

    Johnston, Rhode Island 02919
    United States

    Site Not Available

  • Greenville Dermatology

    Greenville, South Carolina 29607
    United States

    Site Not Available

  • Spartanburg Medical Research

    Spartanburg, South Carolina 29303
    United States

    Site Not Available

  • ClinSearch, LLC

    Chattanooga, Tennessee 37421
    United States

    Site Not Available

  • Tennessee Clinical Research Center

    Nashville, Tennessee 37215
    United States

    Site Not Available

  • J&S Studies, Inc.

    College Station, Texas 77845
    United States

    Site Not Available

  • Center for Clinical Studies

    Houston, Texas 77065
    United States

    Site Not Available

  • Suzanne Bruce and Associates, P.A./The Center for Skin Research

    Houston, Texas 77056
    United States

    Site Not Available

  • Suzanne Bruce and Associates, P.A., The Center for Skin Research

    Katy, Texas 77494
    United States

    Site Not Available

  • R/D Clinical Research, Inc.

    Lake Jackson, Texas 77566
    United States

    Site Not Available

  • Pflugerville Dermatology Clinical Research Center, Inc.

    Pflugerville, Texas 78660
    United States

    Site Not Available

  • ACRC Trials

    Plano, Texas 75024
    United States

    Site Not Available

  • Texas Dermatology and Laser Specialists

    San Antonio, Texas 78218
    United States

    Site Not Available

  • Intermountain Clinical Research

    Draper, Utah 84020
    United States

    Site Not Available

  • The Education and Research Foundation, Inc.

    Lynchburg, Virginia 24501
    United States

    Site Not Available

  • National Clinical Research-Richmond, Inc.

    Richmond, Virginia 23294
    United States

    Site Not Available

  • Dermatology Associates

    Seattle, Washington 98101
    United States

    Site Not Available

  • Eastern Washington Dermatology

    Walla Walla, Washington 99362
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.